Osgood–Schlatter Market Growth, Share, Opportunities and Competitive Analysis Improving Clinical Outcomes
Osgood–Schlatter Market Overview
Osgood–Schlatter
disease (OSD), is inflammation of the knee and area adjacent to knee and is
characterized by a painful bump just below the knee which worsens with
activity. OSD is primarily the disease of growing adolescents especially
experiencing growth spurts. OSD is common in those participating in sports and
other physical activities especially high intensity sports such as running or
jumping. OSD generally resolves with time especially with rest. OSD affects 4%
of people at least once in their lifetime and is more common in males between
the ages of 10 and 15. The male to female ratio is approximately 5:1. The
symptoms of OSD includes knee pain, swelling, tenderness, increased warmth
under the knee and others. In extreme cases OSD may result in fracture.
Market
development represents the best strategy for the market growth. The market is
expected to witness exponential growth over the review period owing to minimal
invasive surgical procedures for the treatment of fractures associated with
OSD.
Competitive Analysis:
Some of the key players profiled in the report are DJO Global, Inc., Teva Pharmaceutical
Industries Ltd., Breg, Inc., Bayer HealthCare Pharmaceuticals LLC, Ossur HF,
Daiichi Sankyo Company, Limited, Pfizer, Inc., Novartis AG, and others.
Segmental Analysis:
The global Osgood-Schlatter market has
been segmented on the basis of diagnosis, treatment and end user.
Based on the diagnosis, the market has
been segmented as physical examination, ultrasonography, X-ray, combination and
other.
Based on the treatment, the market has
been segmented as non-steroidal anti-inflammatory drugs, physical therapy, knee
braces and supports, surgery and others.
Based on the end user, the market has
been segmented as hospitals & clinics, academic and research, and others.
Regional
Analysis:
The Americas accounts for a significant
market share due to high expenditure on the health care and the large sports
culture of the US. Additionally, the fastest uptake of new healthcare products
in the US drives the Osgood-Schlatter market. Furthermore, concentration of the
major healthcare companies and hospitals in the developed countries of this
region coupled with large insurance penetration is adding fuel to the market
growth. Moreover, the US expend high amount on its healthcare, which accounts
for 16% of total GDP, which also increases the sale in Osgood-Schlatter market.
Europe is the second largest market in
the world due to high income, strong healthcare penetration and rising popularity
of sports such as soccer. The European market growth is led by countries such
as Germany and France. The UK is expected to be the fastest growing market over
the assessment period. The strong pharmaceutical industry in Germany is a
strong driver behind the dominance of this country in Europe.
And Many More
About Market
Research Future:
At Market Research Future (MRFR), we enable
our customers to unravel the complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment